Abstract

For many years, the transplantation of hematopoietic stem cells has been used to treat some diseases of the hematopoietic system. For a very long time, only bone marrow was used as a source of hematopoietic stem cells for this method of treatment. However, to comply with allogeneic bone marrow transplantation, an antigenically compatible donor is necessary. Transplantations from unrelated donors are associated with increased risk of a graft-versus-host reaction, transplant rejection and, consequently, increased mortality. Many years ago, it was found that umbilical cord blood as well as bone marrow and peripheral blood contains hematopoietic stem cells and mesenchymal cells able to differentiate into different cell types and that the umbilical cord blood can be a source of stem cells for transplantation. Following this discovery, numerous attempts were made for its potential use in the treatment of hematologic diseases, metabolic diseases as well as regenerative medicine. Umbilical cord blood stem cells exhibit intermediate characteristics between embryonic and adult stem cells. They are distinguished from the latter by telomere length, telomerase activity, and lower risk of accumulation of DNA mutations or chromosomal aberrations. The only transplantation limitation appears to be the amount of cord blood collected, which on average is sufficient for transplantation in a 40-50 kg child. Collection of cord blood is a simple, short-lasting treatment, not causing any danger for a newborn or the mother. Umbilical cord blood is obtained during labor, and then frozen and stored at cord blood banks all over the world.

References

• 1. Ahn S.Y., Chang Y.S., Kim S.Y., Sung D.K., Kim E.S., Rime S.Y., YuW.J., Choi S.J., Oh W.I., Park W.S.: Long-term (postnatal day 70) outcomeand safety of intratracheal transplantation of human umbilicalcord blood-derived mesenchymal stem cells in neonatal hyperoxiclung injury. Yonsei Med. J., 2013; 54: 416-424
  Google Scholar
• 2. Aker M., Varadi G., Slavin S., Nagler A.: Fludarabine-based protocolfor human umbilical cord blood transplantation in childrenwith Fanconi anemia. J. Pediatr. Hematol. Oncol., 1999; 21: 237-239
  Google Scholar
• 3. Almagor Y., Revel-Vilk S., Averbuch D., Mechoulam H., EngelhardD., Resnick I.B., Weintraub M., Stepensky P.: Congenital cytomegalovirusinfection and Wiskott-Aldrich syndrome successfully treatedwith unrelated cord blood transplantation. Pediatr. Blood Cancer,2011; 57: 681-683
  Google Scholar
• 4. Ballen K.K.: New trends in umbilical cord blood transplantation.Blood, 2005; 105: 3786-3792
  Google Scholar
• 5. Beam D., Poe M.D., Provenzale J.M., Szabolcs P., Martin P.L., PrasadV., Parikh S., Driscoll T., Mukundan S., Kurtzberg J., Escolar M.L.:Outcomes of unrelated umbilical cord blood transplantation forX-linked adrenoleukodystrophy. Biol. Blood Marrow Transplant.,2007; 13: 665-674
  Google Scholar
• 6. Benito A., Diaz M.A., Alonso F., Fontán G., Madero L.: Successfulunrelated umbilical cord blood transplantation in a child withOmenn’s syndrome. Pediatr. Hematol. Oncol., 1999; 16: 361-366
  Google Scholar
• 7. Bieback K., Klüter H.: Mesenchymal stromal cells from umbilicalcord blood. Curr. Stem Cell Res. Ther., 2007; 2: 310-323
  Google Scholar
• 8. Bielorai B., Hughes M.R., Auerbach A.D., Nagler A., LoewenthalR., Rechavi G., Toren A.: Successful umbilical cord blood transplantationfor Fanconi anemia using preimplantation genetic diagnosisfor HLA-matched donor. Am. J. Hematol., 2004; 77: 397-399
  Google Scholar
• 9. Boelens J.J., Rocha V., Aldenhoven M., Wynn R., O›Meara A., MichelG., Ionescu I., Parikh S., Prasad V.K., Szabolcs P., Escolar M.,Gluckman E., Cavazzana-Calvo M., Kurtzberg J.: Risk factor analysis ofoutcomes after unrelated cord blood transplantation in patients withHurler syndrome. Biol. Blood Marrow Transplant., 2009; 15: 618-625
  Google Scholar
• 10. Bonno M., Azuma E., Nakano T., Higashikawa M., Kawaski H.,Nishihara H., Obata M., Umemoto M., Sakatoku H., Komada Y., ItoM., Nagai M., Sakurai M.: Successful hematopoietic reconstitutionby transplantation of umbilical cord blood cells in a transfusion–dependent child with Diamond-Blackfan anemia. Bone MarrowTransplant., 1997; 19: 83-85
  Google Scholar
• 11. Botta R., Gao E., Stassi G., Bonci D., Pelosi E., Zwas D., Patti M.,Colonna L., Baiocchi M., Coppola S., Ma X., Condorelli G., PeschleC.: Heart infarct in NOD-SCID mice: therapeutic vasculogenesis bytransplantation of human CD34+ cells ad low dose CD34+KDR+ cells.FASEB J., 2004; 18: 1392-1394
  Google Scholar
• 12. Bużańska L., Jurga M., Stachowiak E.K., Stachowiak M.K., Domańska-JanikK.: Neural stem-like cell line derived from a nonhematopoieticpopulation of human umbilical cord blood. Stem CellsDev., 2006; 15: 391-406
  Google Scholar
• 13. Cable C., Finkel R.S., Lehky T.J., Biassou N.M., Wiggs E.A., BuninN., Pierson T.M.: Unrelated umbilical cord blood transplant for juvenilemetachromatic leukodystrophy: a 5-year follow-up in threeaffected siblings. Mol. Genet. Metab., 2011; 102: 207-209
  Google Scholar
• 14. Chaudhuri A., Hollands P., Bhattacharya N.: Placental umbilicalcord blood transfusion in acute ischaemic stroke. Med. Hypotheses,2007; 69: 1267-1271
  Google Scholar
• 15. Chen C.T., Foo N.H., Liu W.S., Chen S.H.: Infusion of human umbilicalcord blood cells ameliorates hind limb dysfunction in experimentalspinal cord injury through anti-inflammatory, vasculogenicand neurotrophic mechanisms. Pediatr. Neonatol., 2008; 49: 77- 83
  Google Scholar
• 16. Chen J., Sanberg P.R., Li Y., Wang L., Lu M., Willing A.E., Sanchez–Ramos J., Chopp M.: Intravenous administration of human umbilicalcord blood reduces behavioral deficits after stroke in rats. Stroke,2001; 32: 2682-2688
  Google Scholar
• 17. Chen S.H., Chang F.M., Tsai Y.C., Huang K.F., Lin C.L., Lin M.T.:Infusion of human umbilical cord blood cells protect against cerebralischemia and damage during heatstroke in the rat. Exp. Neur.,2006; 199: 67-76
  Google Scholar
• 18. Cheng F.W., Lee V., To K.F., Chan K.C., Shing M.K., Li C.K.: Post–transplant EBV-related lymphoproliferative disorder complicatingumbilical cord blood transplantation in patients of adrenoleukodystrophy.Pediatr. Blood Cancer, 2009; 53: 1329-1331
  Google Scholar
• 19. Childs D.: Sports Medicine Miracles? http://abcnews.go.com/Health/Exercise/story?id=3038931&page=1 (14.05.2014)
  Google Scholar
• 20. Chua S.J., Bielecki R., Yamanaka N., Fehlings M.G., Rogers I.M.,Casper R.F.: The effect of umbilical cord blood cells on outcomes afterexperimental traumatic spinal cord injury. Spine, 2010; 35: 1520-1526
  Google Scholar
• 21. Dusing S.C., Thorpe D.E., Mercer V.S., Rosenberg A.E., Poe M.D.,Escolar M.L.: Temporal and spatial gait characteristics of childrenwith Hurler syndrome after umbilical cord blood transplantation.Phys. Ther., 2007; 87: 978-985
  Google Scholar
• 22. Ende N., Chen R.: Parkinson’s disease mice and human umbilicalcord blood. J. Med., 2002; 33: 173 -180
  Google Scholar
• 23. Ende N., Chen R., Reddi A.S.: Effect of human umbilical cordblood cells on glycemia and insulitis in type 1 diabetic mice. Biochem.Biophys. Res. Comm., 2004; 325: 665-669
  Google Scholar
• 24. Erdogan B., Bavbek M., Sahin I.F., Caner H., Ozen O., DenkbasE.B., Altinors M.N.: Fetal allogeneic umbilical cord cell transplantationimproves motor function in spinal cord-injured rats. Turk.Neurosurg., 2010; 20: 286-294
  Google Scholar
• 25. Escolar M.L., Poe M.D., Provenzale J.M., Richards K.C., Allison J.,Wood S., Wenger D.A., Pietryga D., Wall D., Champagne M., MorseR., Krivit W., Kurtzberg J.: Transplantation of umbilical-cord bloodin babies with infantile Krabbe’s disease. N. Engl. J. Med., 2005; 352:2069-2081
  Google Scholar
• 26. Fang J., Huang S., Chen C., Zhou D.: Unrelated umbilical cordblood transplant for β-thalassemia major. J. Trop. Pediatr., 2003;49: 71-73 27 Fang J., Huang S., Chen C., Zhou D., Li C.K., Li Y., Huang K.: Umbilicalcord blood transplantation in Chinese children with betathalassemia.J. Pediatr. Hematol. Oncol., 2004; 26: 185-189
  Google Scholar
• 27. (Suppl. 2): 112-120 118 Zhao Y., Jiang Z., Zhao T., Ye M., Hu C., Yin Z., Li H., Zhang Y.,Diao Y., Li Y., Chen Y., Sun X., Fisk M.B., Skidgel R., Holterman M.,Prabhakar B., Mazzone T.: Reversal of type 1 diabetes via islet β cellregeneration following immune modulation by cord blood-derivedmultipotent stem cells. BMC Med., 2012; 10: 3 119 Zhao Y., Lin B., Darflinger R., Zhang Y., Holterman M.J., SkidgelR.A.: Human cord blood stem cell-modulated regulatory T lymphocytesreverse the autoimmune-caused type 1 diabetes in nonobesediabetic (NOD) mice. PLoS One 2009; 4: e4226 120 Ziegner U.H., Ochs H.D., Schanen C., Feig S.A., Seyama K., FutataniT., Gross T., Wakim M., Roberts R.L., Rawlings D.J., Dovat S.,Fraser J.K., Stiehm E.R.: Unrelated umbilical cord stem cell transplantationfor X-linked immunodeficiencies. J. Pediatr., 2001; 138: 570-573
  Google Scholar
• 28. Fleitz J., Rumelhart S., Goldman F., Ambruso D., Sokol R.J., PaciniD., Quinones R., Holida M., Lee N., Tannous R., Giller R.: Successfulallogeneic hematopoietic stem cell transplantation (HSCT) forShwachman-Diamond syndrome. Bone Marrow Transplant., 2002;29: 75-79
  Google Scholar
• 29. Garbuzova-Davis S., Gografe S.J., Sanberg C.D., Willing A.E., SaportaS., Cameron D.F., Desjarlais T., Daily J., Kuzmin-Nichols N.,Chamizo W., Klasko S.K., Sanberg P.R.: Maternal transplantation ofhuman umbilical cord blood cells provides prenatal therapy in Sanfilippotype B mouse model. FASEB J., 2006; 20: 485-487 30 Garbuzova-Davis S., Willing A.E., Zigova T., Saporta S., Justen E.B.,Lane J.C., Hudson J.E., Chen N., Davis C.D., Sanberg P.R.: Intravenousadministration of human umbilical cord blood cells in a mouse modelof amyotrophic lateral sclerosis: distribution, migration, and differentiation.J. Hematother. Stem Cell Res., 2003; 12: 255-270
  Google Scholar
• 30. (Suppl. 21): 127-137
  Google Scholar
• 31. Gluckman E., Broxmeyer H.A., Auerbach A.D., Friedman H.S.,Douglas G.W., Devergie A., Esperou H., Thierry D., Socie G., Lehn P.,Cooper S.B., English D., Kurtzberg J., Bard J., Boyse E.A.: Hematopoieticreconstitution in a patient with Fanconi’s anemia by means ofumbilical-cord blood from an HLA-identical sibling. N. Engl. J. Med.,1989; 321: 1174-1178
  Google Scholar
• 32. Goldberg J.L., Laughlin M.J.: UC blood hematopoietic stem cellsand therapeutic angiogenesis. Cytotherapy, 2007; 9: 4-13
  Google Scholar
• 33. Hall J.G., Martin P.L., Wood S., Kurtzberg J.: Unrelated umbilicalcord blood transplantation for an infant with β-thalassemia major.J. Pediatr. Hematol. Oncol., 2004; 26: 382-385
  Google Scholar
• 34. Haller M.J., Viener H.L., Wasserfall C., Brusko T., Atkinson M.A.,Schatz D.A.: Autologous umbilical cord blood infusion for type 1 diabetes.Exp. Hematol., 2008; 36: 710-715
  Google Scholar
• 35. Haller M.J., Wasserfall C.H., Hulme M.A., Cintron M., Brusko T.M.,McGrail K.M., Sumrall T.M., Wingard J.R., Theriaque D.W., ShusterJ.J., Atkinson M.A., Schatz D.A.: Autologous umbilical cord bloodtransfusion in young children with type 1 diabetes fails to preserveC-peptide. Diabetes Care, 2011; 34: 2567-2569
  Google Scholar
• 36. Henning R.J., Abu-Ali H., Balis J.U., Morgan M.B., Willing A.E., SanbergP.R.: Human umbilical cord blood mononuclear cells for treatmentof acute myocardial infarction. Cell Transplant., 2004; 13: 729-739
  Google Scholar
• 37. Henning R.J., Burgos J.D., Ondrovic L., Sanberg P., Balis J., MorganM.B.: Human umbilical cord blood progenitor cells are attracted toinfarcted myocardium and significantly reduce myocardial infarctionsize. Cell Transplant., 2006; 15: 647-658
  Google Scholar
• 38. Hirata Y., Sata M., Motomura N., Takanashi M., Suematsu Y., OnoM., Takamoto S.: Human umbilical cord blood cells improve cardiacfunction after myocardial infarction. Biochem. Biophys. Res. Commun.,2005; 327: 609-614
  Google Scholar
• 39. Jackson L., Jones D.R., Scotting P., Sottile V.: Adult mesenchymalstem cells: differentation potential and therapeutic applications. J.Postgrad. Med., 2007; 53: 121-127
  Google Scholar
• 40. Jaing T.H., Hung I.J., Yang C.P., Chen S.H., Sun C.F., Chow R.:Rapid and complete donor chimerism after unrelated mismatchedcord blood transplantation in 5 children with β-thalassemia major.Biol. Blood Marrow Transplant., 2005; 11: 349-353
  Google Scholar
• 41. Jaing T.H., Tsai B.Y., Chen S.H., Lee W.I., Chang K.W., Chu S.M.:Early transplantation of unrelated cord blood in a two-month-oldinfant with Wiskott-Aldrich syndrome. Pediatr. Transplant., 2007;11: 557-559
  Google Scholar
• 42. Jung K.H., Shin H.P., Lee S., Lim Y.J., Hwang S.H., Han H., ParkH.K., Chung J.H., Yim S.V.: Effect of human umbilical cord bloodderivedmesenchymal stem cells in a cirrhotic rat model. Liver Int.,2009; 29: 898-909
  Google Scholar
• 43. Jung K.H., Uhm Y.K., Lim Y.J., Yim S.V.: Human umbilical cordblood-derived mesenchymal stem cells improve glucose homeostasisin rats with liver cirrhosis. Int. J. Oncol., 2011; 39: 137-143
  Google Scholar
• 44. Kang H.J., Lee J.W., Kim H., Shin H.Y., Ahn H.S.: Successful firstlinetreatment with double umbilical cord blood transplantation insevere aplastic anemia. Bone Marrow Transplant., 2010; 45: 955-956
  Google Scholar
• 45. Kang K.S., Kim S.W., Oh Y.H., Yu J.W., Kim K.Y., Park H.K., SongC.H., Han H.: A thirty-seven-year old spinal cord-injured female patient,transplanted of multipotent stem cells from human UC bloodwith improved sensory perception and mobility, both functionallyand morphologically: a case study. Cytotherapy, 2005; 7: 368-373
  Google Scholar
• 46. Kim B.O., Tian H., Prasongsukarn K., Wu J., Angoulvant D.,Wnendt S., Muhs A., Spitkovsky D., Li R.K.: Cell transplantation improvesventricular function after a myocardial infarction: a preclinicalstudy of human unrestricted somatic stem cells in a porcinemodel. Circulation, 2005; 112 (Suppl. 9): I96-I104
  Google Scholar
• 47. Knutsen A.P., Steffen M., Wassmer K., Wall D.A.: Umbilical cordblood transplantation in Wiskott Aldrich syndrome. J. Pediatr., 2003;142: 519-523
  Google Scholar
• 48. Knutsen A.P., Wall D.A.: Umbilical cord blood transplantationin severe T-cell immunodeficiency disorders: two-year experience.J. Clin. Immunol., 2000; 20: 466-476
  Google Scholar
• 49. Laughlin M.J., Eapen M., Rubinstein P., Wagner J.E., Zhang M.J.,Champlin R.E., Stevens C., Barker J.N., Gale R.P., Lazarus H.M., Marks D.I., van Rood J.J., Scaradavou A., Horowitz M.M.: Outcomes aftertransplantation of cord blood or bone marrow from unrelated donorsin adults with leukemia. N. Engl. J. Med., 2004; 351: 2265-2275
  Google Scholar
• 50. Lee C.C., Yang C.P., Tsai M.H., Lee W.I., Fang E.C., Jaing T.H.:Successful cord blood transplantation in a girl with monosomy 7myelodysplastic syndrome and reduced numbers of B cells. Int. J.Hematol., 2010; 91: 705-707
  Google Scholar
• 51. Lee H., Bae J.S., Jin H.K.: Human umbilical cord blood-derivedmesenchymal stem cells improve neurological abnormalities ofniemann-pick type C mouse by modulation of neuroinflammatorycondition. J. Vet. Med. Sci., 2010; 72: 709-717
  Google Scholar
• 52. Lee H.J., Lee J.K., Lee H., Carter J.E., Chang J.W., Oh W., Yang Y.S.,Suh J.G., Lee B.H., Jin H.K., Bae J.S.: Human umbilical cord blood-derivedmesenchymal stem cells improve neuropathology and cognitiveimpairment in an Alzheimer’s disease mouse model throughmodulation of neuroinflammation. Neurobiol. Aging, 2012; 33: 588-602
  Google Scholar
• 53. Lee H.J., Lee J.K., Lee H., Shin J.W., Carter J.E., Sakamoto T., JinH.K., Bae J.S.: The therapeutic potential of human umbilical cordblood-derived mesenchymal stem cells in Alzheimer’s disease. Neurosci.Lett., 2010; 481: 30-35
  Google Scholar
• 54. Lee J.W., Kang H.J., Kim E.K., Shin H.Y., Ahn H.S.: Successful salvageunrelated umbilical cord blood transplantation with two unitsafter engraftment failure with single unit in severe aplastic anemia.J. Korean Med. Sci., 2009; 24: 744-746
  Google Scholar
• 55. Lee V., Li C.K., Shing M.M., Chik K.W., Lam C.W., Tsang K.S., PongH., Huen K.F., Yuen P.M.: Umbilical cord blood transplantation forMaroteaux-Lamy syndrome (mucopolysaccharidosis type VI). BoneMarrow Transplant., 2000; 26: 455-458
  Google Scholar
• 56. Leor J., Guetta E., Feinberg M.S., Galski H., Bar I., Holbova R.,Miller L., Zarin P., Castel P., Barbash I.M., Nagler A.: Human umbilicalcord blood-derived CD133+ cells enhance function and repair ofthe infarcted myocardium. Stem Cells, 2006; 24: 772-780
  Google Scholar
• 57. Li X.H., Gao C.J., Da W.M., Cao J.B., Wang Z.H., Xu L.X., Wu Y.M.,Liu B., Liu Z.Y., Yan B., Li S.W., Yang X.L., Wu X.X., Han Z.C.: Reducedintensity conditioning, combined transplantation of haploidenticalhematopoietic stem cells and mesenchymal stem cells in patientswith severe aplastic anemia. PLoS One, 2014; 9: e89666
  Google Scholar
• 58. Lu D., Sanberg P.R., Mahmood A., Li Y., Wang L., Sanchez-RamosJ., Chopp M.: Intravenous administration of human umbilical cordblood reduces neurological deficit in the rat after traumatic braininjury. Cell Transplant., 2002; 11: 275-281
  Google Scholar
• 59. Lv Y.T., Zhang Y., Liu M., Qiuwaxi J.N., Ashwood P., Cho S.C., HuanY., Ge R.C., Chen X.W., Wang Z.J., Kim B.J., Hu X.: Transplantation ofhuman cord blood mononuclear cells and umbilical cord-derivedmesenchymal stem cells in autism. J. Transl. Med., 2013; 11: 196
  Google Scholar
• 60. Ma N., Stamm C., Kaminski A., Li W., Kleine H.D., Müller-HilkeB., Zhang L., Ladilov Y., Egger D., Steinhoff G.: Human cord bloodcells induce angiogenesis following myocardial infarction in NOD/scid-mice. Cardiovasc. Res., 2005; 66: 45-54
  Google Scholar
• 61. Majhail N.S., Weisdorf D.J., Wagner J.E., Defor T.E., BrunsteinC.G., Burns L.J.: Comparable results of umbilical cord blood and HLAmatchedsibling donor hematopoietic stem cell transplantation afterreduced-intensity preparative regimen for advanced Hodgkinlymphoma. Blood, 2006; 107: 3804-3807
  Google Scholar
• 62. Martin H.R., Poe M.D., Provenzale J.M., Kurtzberg J., MendizabalA., Escolar M.L.: Neurodevelopmental outcomes of umbilical cordblood transplantation in metachromatic leukodystrophy. Biol. BloodMarrow Transplant., 2013; 19: 616-624
  Google Scholar
• 63. Martin P.L., Carter S.L., Kernan N.A., Sahdev I., Wall D., PietrygaD., Wagner J.E., Kurtzberg J.: Results of the cord blood transplantationstudy (COBLT): outcomes of unrelated donor umbilical cord bloodtransplantation in pediatric patients with lysosomal and peroxisomalstorage diseases. Biol. Blood Marrow Transplant., 2006; 12: 184-194
  Google Scholar
• 64. McGuckin C., Forraz N., Baradez M.O., Basford C., Dickinson A.M.,Navran S., Hartgerink J.D.: Embryonic-like stem cells from umbilicalcord blood and potential for neural modeling. Acta Neurobiol.Exp., 2006; 66: 321-329
  Google Scholar
• 65. McGuckin C.P., Forraz N., Baradez M.O., Navran S., Zhao J., UrbanR., Tilton R., Denner L.: Production of stem cells with embryoniccharacteristics from human umbilical cord blood. Cell Prolif.,2005; 38: 245-255
  Google Scholar
• 66. Meier C., Middelanis J., Wasielewski B., Neuhoff S., Roth-HaererA., Gantert M., Dinse H.R., Dermietzel R., Jensen A.: Spastic paresisafter perinatal brain damage in rats is reduced by human cord bloodmononuclear cells. Pediatr. Res., 2006; 59: 244-249
  Google Scholar
• 67. Michel G., Rocha V., Chevret S., Arcese W., Chan K.W., FilipovichA., Takahashi T.A., Vowels M., Ortega J., Bordigoni P., Shaw P.J., YanivI., Machado A., Pimentel P., Fagioli F. i wsp.: Unrelated cord bloodtransplantation for childhood acute myeloid leukemia: a EurocordGroup analysis. Blood, 2003; 102: 4290-4297
  Google Scholar
• 68. Monz D., Tutdibi E., Mildau C., Shen J., Kasoha M., Laschke M.W.,Roolfs T., Schmiedl A., Tschernig T., Bieback K., Gortner L.: Humanumbilical cord blood mononuclear cells in a double-hit model ofbronchopulmonary dysplasia in neonatal mice. PLoS One, 2013; 8:e74740
  Google Scholar
• 69. Newcomb J.D., Ajmo C.T.Jr., Sanberg C.D., Sanberg P.R., PennypackerK.R., Willing A.E.: Timing of cord blood treatment after experimentalstroke determines therapeutic efficacy. Cell Transplant.,2006; 15: 213-223
  Google Scholar
• 70. Newman M.B., Willing A.E., Manresa J.J., Sanberg C.D., SanbergP.R.: Cytokines produced by cultured human umbilical cord blood(HUCB) cells: implications for brain repair. Exp. Neurol., 2006; 199:201-208
  Google Scholar
• 71. Nishiyama N., Miyoshi S., Hida N., Uyama T., Okamoto K., IkegamiY., Miyado K., Segawa K., Terai M., Sakamoto M., Ogawa S.,Umezawa A.: The significant cardiomyogenic potential of humanumbilical cord blood-derived mesenchymal stem cells in vitro. StemCells, 2007; 25: 2017-2024
  Google Scholar
• 72. Parikh S.H., Mendizabal A., Martin P.L., Prasad V.K., SzabolcsP., Driscoll T.A., Kurtzberg J.: Unrelated donor umbilical cord bloodtransplantation in pediatric myelodysplastic syndrome: a singlecenterexperience. Biol. Blood Marrow Transplant., 2009; 15: 948-955
  Google Scholar
• 73. Pesce M., Orlandi A., Iachininoto M.G., Straino S., Torella A.R.,Rizzuti V., Pompilio G., Bonanno G., Scambia G., Capogrossi M.C.:Myoendothelial differentiation of human umbilical cord blood-derivedstem cells in ischemic limb tissues. Circ. Res., 2003; 93: e51-e62
  Google Scholar
• 74. Pierro M., Ionescu L., Montemurro T., Vadivel A., WeissmannG., Oudit G., Emery D., Bodiga S., Eaton F., Péault B., Mosca F., LazzariL., Thébaud B.: Short-term, long-term and paracrine effect ofhuman umbilical cord-derived stem cells in lung injury preventionand repair in experimental bronchopulmonary dysplasia. Thorax,2013; 68: 475-484
  Google Scholar
• 75. Pimentel-Coelho P.M., Magalhães E.S., Lopes L.M., deAzevedoL.C., Santiago M.F., Mendez-Otero R.: Human cord blood transplantationin a neonatal rat model of hypoxic-ischemic brain damage:functional outcome related to neuroprotection in the striatum. StemCells Dev., 2010; 19: 351-358
  Google Scholar
• 76. Pojda Z., Machaj E.K., Gajkowska A., Ołdak T., Jastrzewska M.:Badanie potencjalnej przydatności klinicznej komórek macierzystychuzyskiwanych z krwi pępowinowej. Postępy Biol. Kom., 2003;
  Google Scholar
• 77. Prasad V.K., Kurtzberg J.: Cord blood and bone marrow transplantationin inherited metabolic diseases: scientific basis, currentstatus and future directions. Br. J. Haematol., 2010; 148: 356-372
  Google Scholar
• 78. Prasad V.K., Mendizabal A., Parikh S.H., Szabolcs P., DriscollT.A., Page K., Lakshminarayanan S., Allison J., Wood S., Semmel D.,Escolar M.L., Martin P.L., Carter S., Kurtzberg J.: Unrelated donor umbilical cord blood transplantation for inherited metabolic disordersin 159 pediatric patients from a single center: influence of cellularcomposition of the graft on transplantation outcomes. Blood,2008; 112: 2979-2989
  Google Scholar
• 79. Raghavan S., Zeng B., Torres P.A., Pastores G.M., Kolodny E.H.,Kurtzberg J., Krivit W.: Globoid cell leukodystrophy (Krabbe disease):Normal umbilical cord blood galactocerebrosidase activity andpolymorphic mutations. J. Inherit. Metab. Dis., 2005; 28: 1005-1009
  Google Scholar
• 80. Revoltella R.P., Papini S., Rosellini A., Michelini M., FranceschiniV., Ciorba A., Bertolaso L., Magosso S., Hatzopoulos S., Lorito G., GiordanoP., Simoni E., Ognio E., Cilli M., Saccardi R., Urbani S., Jeffery R.,Poulsom R., Martini A.: Cochlear repair by transplantation of humancord blood CD133+ cells to nod-scid mice made deaf with kanamycinand noise. Cell Transplant., 2008; 17: 665-678
  Google Scholar
• 81. Rocha V., Cornish J., Sievers E.L., Filipovich A., Locatelli F., PetersC., Remberger M., Michel G., Arcese W., Dallorso S., Tiedemann K.,Busca A., Chan K.W., Kato S., Ortega J. i wsp.: Comparison of outcomesof unrelated bone marrow and umbilical cord blood transplants inchildren with acute leukemia. Blood, 2001; 97: 2962-2971
  Google Scholar
• 82. Rocha V., Labopin M., Sanz G., Arcese W., Schwerdtfeger R., BosiA., Jacobsen N., Ruutu T., de Lima M., Finke J., Frassoni F., GluckmanE., Acute Leukemia Working Party of European Blood and MarrowTransplant Group; Eurocord-Netcord Registry: Transplants of umbilical-cordblood or bone marrow from unrelated donors in adultswith acute leukemia. N. Engl. J. Med., 2004; 351: 2276-2285
  Google Scholar
• 83. Rubinstein P.: Placental blood-derived hematopoietic stem cells forunrelated bone marrow reconstitution. J. Hematother., 1993; 2: 207-210
  Google Scholar
• 84. Sanz J., Montesinos P., Saavedra S., Lorenzo I., Senent L., PlanellesD., Larrea L., Martín G., Palau J., Jarque I., Martínez J., de la Rubia J.,Moscardó F., Martinez D., Gómez I. i wsp.: Single-unit umbilical cordblood transplantation from unrelated donors in adult patients withchronic myelogenous leukemia. Biol. Blood Marrow Transplant.,2010; 16: 1589-1595
  Google Scholar
• 85. Saporta S., Kim J.J., Willing A.E., Fu E.S., Davis C.D., Sanberg P.R.:Human umbilical cord blood stem cells infusion in spinal cord injury:engraftment and beneficial influence on behavior. J. Hematother.Stem Cell Res., 2003; 12: 271-278
  Google Scholar
• 86. Schmidt D., Breymann C., Weber A., Guenter C.I., NeuenschwanderS., Zund G., Turina M., Hoerstrup S.P.: Umbilical cordblood derived endothelial progenitor cells for tissue engineering ofvascular grafts. Ann. Thorac. Surg., 2004; 78: 2094-2098
  Google Scholar
• 87. Seo Y., Yang S.R., Jee M.K., Joo E.K., Roh K.H., Seo M.S., HanT.H., Lee S.Y., Ryu P.D., Jung J.W., Seo K.W., Kang S.K., Kang K.S.: Humanumbilical cord blood-derived mesenchymal stem cells protectagainst neuronal cell death and ameliorate motor deficits in NiemannPick type C1 mice. Cell Transplant., 2011; 20: 1033-1047
  Google Scholar
• 88. Shyu M.K., Yuan R.H., Shih J.C., Wu M.Z., Chen H.L., Kuo Y.C.,Chien C.L., Chow L.P., Chen H.L., Hsieh F.J.: Kinetics and functionalassay of liver repopulation after human cord blood transplantation.Dig. Liver Dis., 2007; 39: 455-465
  Google Scholar
• 89. Stojko R., Witek A.: Krew pępowinowa – doskonałe źródło komórekmacierzystych. Ginekol. Pol., 2005; 76: 491-497
  Google Scholar
• 90. Sun B., Roh K.H., Lee S.R., Lee Y.S., Kang K.S.: Induction of humanumbilical cord blood-derived stem cells with embryonic stemcell phenotypes into insulin producing islet-like structure. Biochem.Biophys. Res. Commun., 2007; 354: 919-923
  Google Scholar
• 91. Sun L., Wang D., Liang J., Zhang H., Feng X., Wang H., Hua B.,Liu B., Ye S., Hu X., Xu W., Zeng X., Hou Y., Gilkeson G.S., Silver R.M.,Lu L., Shi S.: Umbilical cord mesenchymal stem cell transplantationin severe and refractory systemic lupus erythematosus. ArthritisRheum., 2010; 62: 2467-2475
  Google Scholar
• 92. Sunkomat J.N., Harris D.T., Hoang Thai, Goldman S., Gaballa M.A.:Intracoronary delivery of cord blood-derived MNCs & CD34+ cells inan ischemia-reperfusion model. J. Mol. Cell. Cardiol., 2007; 42: S97 [93] Szabolcs P., Park K.D., Reese M., Marti L., Broadwater G., KurtzbergJ.: Coexistent naive phenotype and higher cycling rate of cordblood T cells as compared to adult peripheral blood. Exp. Hematol.,2003; 31: 708-714 94 Szivek J.A., Wiley D., Cox L., Harris D., Margolis D.S., Grana W.A.:Stem cells grown in dynamic culture on micropatterned surfacescan be used to engineer cartilage-like tissue. Orthopaedic ResearchSociety Meeting. San Diego, USA; 2007 95 Taga T., Itoh E., Noda Y., Kato H., Maruo Y., Takano T., Ohta S.,Takeuchi Y., Kumaki S.: Successful unrelated umbilical cord blood celltransplantation without conditioning for a neonate with severe combinedimmunodeficiency. Pediatr. Transplant., 2011; 15: E152-E155 96 Tajika K., Mizuki T., Nakayama K., Yamaguchi H., Dan K.: Umbilical-cordblood cell transplantation conditioned with a reducedintensity-regimen is a practical salvage therapy for severe aplasticanemia refractory to immunosuppressive therapy with antithymocyteglobulin/ciclosporin. J. Nippon Med. Sch., 2007; 74: 424-429 97 Tokimasa S., Ohta H., Takizawa S., Kusuki S., Hashii Y., Sakai N.,Taniike M., Ozono K., Hara J.: Umbilical cord-blood transplantationsfrom unrelated donors in patients with inherited metabolic diseases:single-institute experience. Pediatr. Transplant., 2008; 12: 672-676 98 Toren A., Nagler A., Amariglio N., Neumann Y., Golan H., BiloriB., Kaplinsky C., Mandel M., Biniaminov M., Levanon M., RosenthalE., Davidson J., Brok-Simoni F., Rechavi G.: Successful human umbilicalcord blood stem cell transplantation without conditioningin severe combined immune deficiency. Bone Marrow Transplant.,1999; 23: 405-408 99 Tsuji Y., Imai K., Kajiwara M., Aoki Y., Isoda T., Tomizawa D.,Imai M., Ito S., Maeda H., Minegishi Y., Ohkawa H., Yata J., Sasaki N.,Kogawa K., Nagasawa M., Morio T., Nonoyama S., Mizutani S.: Hematopoieticstem cell transplantation for 30 patients with primaryimmunodeficiency diseases: 20 years experience of a single team.Bone Marrow Transplant., 2006; 37: 469-477 100 Urban C., Lackner H., Sovinz P., Benesch M., Schwinger W.,Dornbusch H.J., Moser A.: Successful unrelated cord blood transplantationin a 7-year-old boy with Evans syndrome refractory toimmunosuppression and double autologous stem cell transplantation.Eur. J. Haematol., 2006: 76: 526-530 101 Veeravalli K.K., Dasari V.R., Tsung A.J., Dinh D.H., Gujrati M.,Fassett D., Rao J.S.: Human umbilical cord blood stem cells upregulatematrix metalloproteinase-2 in rats after spinal cord injury. Neurobiol.Dis., 2009; 36: 200-212 102 Vendrame M., Cassady J., Newcomb J., Butler T., PennypackerK.R., Zigova T., Sanberg C.D., Sanberg P.R., Willing A.E.: Infusion ofhuman umbilical cord blood cells in a rat model of stroke dose-dependentlyrescues behavioral deficits and reduces infarct volume.Stroke, 2004; 35: 2390-2395 103 Vendrame M., Gemma C., de Mesquita D., Collier L., BickfordP.C., Sanberg C.D., Sanberg P.R., Pennypacker K.R., Willing A.E.: Antiinflammatoryeffects of human cord blood cells in a rat model ofstroke. Stem Cells Dev., 2005; 14: 595-604 104 Vibhakar R., Radhi M., Rumelhart S., Tatman D., Goldman F.:Successful unrelated umbilical cord blood transplantation in childrenwith Shwachman-Diamond syndrome. Bone Marrow Transplant.,2005; 36: 855-861 105 Wagner J.E., Rosenthal J., Sweetman R., Shu X.O., Davies S.M.,Ramsay N.K., McGlave P.B., Sender L., Cairo M.S.: Successful transplantationof HLA-matched and HLA-mismatched umbilical cordblood from unrelated donors: analysis of engraftment and acutegraft-versus-host disease. Blood, 1996; 88: 795-802 106 Wang F.S., Yang K.D., Wang C.J., Huang H.C., Chio C.C., Hsu T.Y.,Ou C.Y.: Shockwave stimulates oxygen radical-mediated osteogenesisof the mesenchymal cells from human umbilical cord blood. J. BoneMiner. Res., 2004; 19: 973-982 107 Wang H., Qiu X., Ni P., Qiu X., Lin X., Wu W., Xie L., Lin L., MinJ., Lai X., Chen Y., Ho G., Ma L.: Immunological characteristics of humanumbilical cord mesenchymal stem cells and the therapeuticeffects of their transplantation on hyperglycemia in diabetic rats.Int. J. Mol. Med., 2014; 33: 263-270 108 Wang H., Wang Z., Zheng X., Ding L., Zhu L., Yan H., Guo Z.:Hematopoietic stem cell transplantation with umbilical cord multipotentstromal cell infusion for the treatment of aplastic anemia- a single-center experience. Cytotherapy, 2013; 15: 1118-1125 109 Willing A.E., Lixian J., Milliken M., Poulos S., Zigova T., SongS., Hart C., Sanchez-Ramos J., Sanberg P.R.: Intravenous versus intrastriatalcord blood administration in a rodent model of stroke. J.Neurosci. Res., 2003; 73: 296-307 110 Wu K.H., Zhou B., Mo X.M., Cui B., Yu C.T., Lu S.H., Han Z.C., LiuY.L.: Therapeutic potential of human umbilical cord-derived stemcells in ischemic diseases. Transplant. Proc., 2007; 39: 1620-1622 111 Xiao J., Nan Z., Motooka Y., Low W.C.: Transplantation of a novelcell line population of umbilical cord blood stem cells amelioratesneurological deficits associated with ischemic brain injury. StemCells Dev., 2005; 14: 722-733 112 Xiao N., Zhao X., Luo P., Guo J., Zhao Q., Lu G., Cheng L.: Cotransplantationof mesenchymal stromal cells and cord blood cellsin treatment of diabetes. Cytotherapy, 2013; 15: 1374-1384 113 Yasuhara T., Hara K., Maki M., Xu L., Yu G., Ali M.M., MasudaT., Yu S.J., Bae E.K., Hayashi T., Matsukawa N., Kaneko Y., KuzminNicholsN., Ellovitch S., Cruz E.L. i wsp.: Mannitol facilitates neurotrophicfactor up-regulation and behavioural recovery in neonatalhypoxic-ischaemic rats with human umbilical cord blood grafts. J.Cell. Mol. Med., 2010; 14: 914-921 114 Yin Y., Ren H.Y., Cen X.A., Qiu Z.X., Ou J.P., Wang W.S., Wang M.J.,Xu W.L., Wang L.H., Li Y., Dong Y.J.: Long-term outcomes in adultswith leukemia treated with transplantation of two unrelated umbilicalcord blood units. Chin. Med. J., 2011; 124: 2411-2416 115 Yoshimasu T., Tanaka R., Suenobu S., Yagasaki H., Yoshino H.,Ueda T., Hisakawa H., Ishii T., Mitsui T., Ebihara Y., Manabe A., IsekiT., Maekawa T., Nakahata T., Asano S., Tsuji K.: Prompt and durablehematopoietic reconstitution by unrelated cord blood transplantationin a child with Fanconi anemia. Bone Marrow Transplant.,2001; 27: 767-769 116 Yoshimi A., Kojima S., Taniguchi S., Hara J., Matsui T., TakahashiY., Azuma H., Kato K., Nagamura-Inoue T., Kai S., Kato S., JapanCord Blood Bank Network: Unrelated cord blood transplantationfor severe plastic anemia. Biol. Blood Marrow Transplant., 2008;14: 1057-1063 117 Zhang Z., Lin H., Shi M., Xu R., Fu J., Lv J., Chen L., Lv S., Li Y.,Yu S., Geng H., Jin L., Lau G.K., Wang F.S.: Human umbilical cord mesenchymalstem cells improve liver function and ascites in decompensatedliver cirrhosis patients. J. Gastroenterol. Hepatol., 2012;
  Google Scholar

Full text